Ovid Therapeutics Inc. (OVID) — Stock Score Summary

Ovid Therapeutics Inc. (OVID) has a MoatMap StockRank of 48/100 based on Quality (34/100), Value (38/100), and Momentum (63/100) factor scores. The current signal is HOLD. Ovid Therapeutics is a micro-cap biotech with high binary trial risk and no established commercial moat, making it unsuitable for a high-conviction portfolio.

Ovid Therapeutics Inc. is a clinical-stage biopharmaceutical company dedicated to developing novel therapies for rare neurological diseases, with a particular focus on genetic epilepsies and other brain disorders. The company's strategy involves targeting orphan conditions with high unmet medical needs, which could lead to accelerated regulatory pathways and market exclusivity upon approval. Ovid's competitive differentiation comes from its proprietary drug discovery platform and strategic partnerships aimed at advancing promising pipeline candidates.

Key Financial Metrics

Price$2.56
Market Cap$493M
P/E (Forward)-5.42
Price/Book2.44
Return on Equity-18.8%
Return on Invested Capital-29.8%
Debt/Equity6.59
Gross Margin100.0%
Operating Margin-670.2%
Free Cash Flow$-20M

Ovid Therapeutics Inc. operates in the Biotechnology industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Ovid Therapeutics Inc.’s (OVID) StockRank?
MoatMap’s StockRank for Ovid Therapeutics Inc. (OVID) is 48/100, with a Hold signal. It is a composite of Quality (34), Value (38), and Momentum (63) factor ranks across MoatMap’s 19,000+ stock universe.
Does Ovid Therapeutics Inc. have an economic moat?
Ovid Therapeutics Inc. (OVID) has a Quality factor score of 34/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Ovid Therapeutics Inc. a buy, hold, or sell?
MoatMap’s current signal for Ovid Therapeutics Inc. (OVID) is Hold, based on a StockRank of 48/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Ovid Therapeutics Inc. in?
Ovid Therapeutics Inc. (OVID) operates in the Healthcare sector, specifically the Biotechnology industry (United States).
Browse all ranked stocksOVID deep dive reportAI ChampionsHow we score stocksSense-check another stock